Companies/CN/300765

新诺威 · CSPC INNOVATION PHARMACEUTICAL CO., LTD.

Ownership & governance

Executives 3Directors 10Avg age 51Avg tenure 4.8y
Bing Yao
Chief Executive Officer
Age 49Since 2024-04-21

Executives3

Bing Yao
Chief Executive Officer
Age 49Since 2024-04-21
Long Dai
Director of Finance/CFO
Age 34Since 2023-04-06
Tai On Lo
Corporate Secretary
Age 71—

Board of directors10

Feng Han
Director/Board Member
Age 52Since 2015-12-31
Ji Yong Zhang
Chairman
Age 50Since 2015-12-31
Lei Cai
Director/Board Member
Age 46Since 2020-09-06
Ling Zhang
Director/Board Member
Age 45Since 2020-07-30
Bin Yuan
Director/Board Member
Age 54Since 2020-04-09
Bing Yao
Chairman
Age 49Since 2024-09-22
Di Bin Li
Director/Board Member
Age 68Since 2023-04-06
Cong Zhi Di
Director/Board Member
Age 51Since 2023-04-06

Shareholders5

NameStakeShares
CSPC PHARMACEUTICAL GROUP LIMITED
73.83 %
1,037,058,294
ICBC UBS Asset Management Co. Ltd.
1.511 %
21,217,553
Bank of China Investment Management Co., Ltd.
0.6338 %
8,902,187
China Asset Management Co., Ltd.
0.4927 %
6,920,223
Zhong Ou Asset Management Co., Ltd
0.3138 %
4,408,017

Catalog · 2026-07-09

SEC officers14

NameRoleSinceShares
刘刚叁副总经理—-
姚兵董事—-
张玲监事—-
张继勇监事会主席—-
李迪斌独立董事—-
杨栋董事—-
杨鹏独立董事—-
潘卫东董事长—-

SEC · as of 2026-07-09

Institutional (13F)

Loading Form 13F holders…

Fund membership

Loading fund baskets…

Street consensus

Consensus noneMean target 59.47Range 57–61.4Analysts 3
57Mean 59.4761.4
  • Strong buy 1
  • Buy 2

Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.

Peers